G. Metan Et Al. , "Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients," JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.354-357, 2015
Metan, G. Et Al. 2015. Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients. JOURNAL OF CHEMOTHERAPY , vol.27, no.6 , 354-357.
Metan, G., TÜRE YÜCE, Z., KAYNAR, L., Berk, E., GÜRSOY, Ş., Alp, E., ... Kılıç, H.(2015). Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients. JOURNAL OF CHEMOTHERAPY , vol.27, no.6, 354-357.
Metan, Gökhan Et Al. "Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients," JOURNAL OF CHEMOTHERAPY , vol.27, no.6, 354-357, 2015
Metan, Gökhan Et Al. "Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients." JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.354-357, 2015
Metan, G. Et Al. (2015) . "Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients." JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.354-357.
@article{article, author={Gökhan Metan Et Al. }, title={Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients}, journal={JOURNAL OF CHEMOTHERAPY}, year=2015, pages={354-357} }